GGrantIndex
← Leaderboards

Mary Jo Ladu

Evanston Northwestern Healthcare Res Ins

Google Scholar ↗PubMed ↗ORCID ↗
$10,285,749
Attributed
$14,840,596
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.6M · FY2005–20
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$24,208,414 · 15

By mechanism

P01$13,388,975 · 5
RF1$3,816,871 · 1
R01$3,602,209 · 2
R21$1,606,190 · 4
R56$840,770 · 1
UH3$714,496 · 1

Top collaborators

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposApolipoprotein ES DiseaseBaseBrainMouse ModelTransgenic MiceAmyloid Beta-ProteinApolipoprotein E-4Protein IsoformsGenetic Risk FactorProgramsMutationAmyloidPathologyPathway InteractionsFamilial Alzheimer DiseaseS Disease RiskDementiaAllelesEpidemicGeneticProteinsIn Vitro

Grant awards (51)

Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice$635,706
R01 · FY2020 · AG · contact PI
Aged EFAD mice as a model for the effects of APOE and sex on AD pathology$239,850
UH3 · FY2020 · NS · contact PI
Characterization of protective roles of ApoE2 against aging and Alzheimer's disease$840,770
R56 · FY2019 · AG
Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice$591,148
R01 · FY2019 · AG
Aged EFAD mice as a model for the effects of APOE and sex on AD pathology$279,825
UH3 · FY2019 · NS · contact PI
R01 Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice$70,750
R01 · FY2019 · AG
Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice$600,903
R01 · FY2018 · AG
Aged EFAD mice as a model for the effects of APOE and sex on AD pathology$194,821
UH3 · FY2018 · NS · contact PI
Sex differences in the relationship between APOE and AD: Role of sexual differentiation$3,816,871
RF1 · FY2017 · AG
Estrogen therapy and APOE4 risk in Alzheimer's tested in female EFAD mice$578,095
R01 · FY2017 · AG
Aged EFAD mice as a model for the effects of APOE and sex on AD pathology$158,953
UH2 · FY2017 · NS · contact PI
Preclinical assessment of an ABCA1 agonist as a novel therapeutic for AD$239,825
R21 · FY2016 · AG · contact PI
Aged EFAD mice as a model for the effects of APOE and sex on AD pathology$79,950
UH2 · FY2016 · NS · contact PI
TLR4 antagonists as a therapeutic treatment for APOE-modulated neuroinflammation$232,509
R21 · FY2015 · AG · contact PI
Preclinical assessment of an ABCA1 agonist as a novel therapeutic for AD$199,750
R21 · FY2015 · AG · contact PI
Potential ApoE Isoform-Specific Detrimental Effects of RXR Agonists in Alzheimer'$189,324
R21 · FY2015 · AG
Potential ApoE Isoform-Specific Detrimental Effects of RXR Agonists in Alzheimer'$233,581
R21 · FY2014 · AG
TLR4 antagonists as a therapeutic treatment for APOE-modulated neuroinflammation$199,750
R21 · FY2014 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$1,750,382
P01 · FY2013 · AG · contact PI
TRANSGENIC MOUSE CORE$253,669
P01 · FY2013 · AG · contact PI
REGULATION OF APOE METABOLISM BY APOE RECEPTORS AND AB IN NEURONS$238,460
P01 · FY2013 · AG · contact PI
ADMINISTRATIVE$151,844
P01 · FY2013 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$1,885,220
P01 · FY2012 · AG · contact PI
TRANSGENIC MOUSE CORE$299,603
P01 · FY2012 · AG · contact PI
REGULATION OF APOE METABOLISM BY APOE RECEPTORS AND AB IN NEURONS$252,340
P01 · FY2012 · AG · contact PI
ADMINISTRATIVE$160,680
P01 · FY2012 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$1,878,193
P01 · FY2011 · AG · contact PI
REGULATION OF APOE METABOLISM BY APOE RECEPTORS AND AB IN NEURONS$260,748
P01 · FY2011 · AG · contact PI
TRANSGENIC MOUSE CORE$237,872
P01 · FY2011 · AG · contact PI
ADMINISTRATIVE$166,035
P01 · FY2011 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$1,851,511
P01 · FY2010 · AG · contact PI
REGULATION OF APOE METABOLISM BY APOE RECEPTORS AND AB IN NEURONS$264,446
P01 · FY2010 · AG · contact PI
TRANSGENIC MOUSE CORE$223,109
P01 · FY2010 · AG · contact PI
ADMINISTRATIVE$167,743
P01 · FY2010 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$63,038
P01 · FY2010 · AG · contact PI
ApoE Receptor Biology and Neurodegeneration$1,939,474
P01 · FY2009 · AG · contact PI
REGULATION OF APOE METABOLISM BY APOE RECEPTORS AND AB IN NEURONS$249,961
P01 · FY2009 · AG · contact PI
TRANSGENIC MOUSE CORE$192,108
P01 · FY2009 · AG · contact PI
ADMINISTRATIVE$159,170
P01 · FY2009 · AG · contact PI
REGULATION OF NEUROINFLAMMATION BY ApoE AND ApoE RECEPTORS$387,953
P01 · FY2007 · AG · contact PI
REGULATION OF NEUROINFLAMMATION BY ApoE /ApoE RECEPTORS$355,416
P01 · FY2006 · AG · contact PI
Amyloid beta conformation-specific monoclonal antibodies$170,575
R21 · FY2005 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$196,210
R01 · FY2004 · AG
Amyloid beta conformation-specific monoclonal antibodies$140,876
R21 · FY2004 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$25,558
R01 · FY2004 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$252,810
R01 · FY2003 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$209,040
R01 · FY2002 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$37,500
R01 · FY2002 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$202,950
R01 · FY2001 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$4,500
R01 · FY2001 · AG
APOE AND BETA AMYLOID INTERACTIONS--EFFECTS ON NEUROTOX$197,039
R01 · FY2000 · AG